Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
49 NC counties are under alert, including Johnston and Chatham counties.
Closings
16 closings/delays reported.
Just In
Water rescue: More than 25 people rescued from flood waters Friday in Rutherford County, local EMS says
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Qiagen N.V.
(NY:
QGEN
)
45.24
+0.22 (+0.49%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,970,639
Open
45.70
Bid (Size)
45.24 (10)
Ask (Size)
46.40 (1)
Prev. Close
45.02
Today's Range
45.22 - 46.08
52wk Range
34.74 - 47.44
Shares Outstanding
227,985,334
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
August 06, 2024
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
July 16, 2024
Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.
Via
MarketBeat
Performance
YTD
+3.64%
+3.64%
1 Month
-1.69%
-1.69%
3 Month
+10.07%
+10.07%
6 Month
+5.23%
+5.23%
1 Year
+14.62%
+14.62%
More News
Read More
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation
June 24, 2024
Via
Benzinga
Exposures
Product Safety
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 20, 2024
Via
Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For February 6, 2024
February 06, 2024
Via
Benzinga
Earnings Preview: Qiagen
February 05, 2024
Via
Benzinga
Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches
June 17, 2024
Via
Benzinga
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
May 30, 2024
From
Myriad Genetics, Inc.
Via
GlobeNewswire
QGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024
April 29, 2024
Via
InvestorPlace
US Stocks Set To Approach New Week With Caution Ahead Of Fed Meeting, Tech Earnings: Analyst Says 'Buy The Dip' Contingent On This Condition
April 29, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Where Qiagen Stands With Analysts
December 07, 2023
Via
Benzinga
Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
May 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Expectations for Qiagen's Future
November 02, 2023
Via
Benzinga
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
April 29, 2024
Via
Benzinga
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
January 17, 2024
Via
Benzinga
Qiagen's Health Odyssey: Expanding In Riyadh And Partnering In Public Projects
January 03, 2024
Via
Benzinga
Preview: Qiagen's Earnings
October 27, 2023
Via
Benzinga
Analyst Expectations for Qiagen's Future
October 17, 2023
Via
Benzinga
Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock
December 07, 2023
Via
Benzinga
These Companies Helped The German DAX Index Hit Its All-time High
December 06, 2023
Via
Talk Markets
Diagnostic Firm Qiagen's Q3 Earnings: Analyst Says Annual Projections Attainable Despite Macro Trends
October 31, 2023
Via
Benzinga
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
October 26, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Earnings Scheduled For October 30, 2023
October 30, 2023
Via
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
Via
Benzinga
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.